A team of 110 researchers and clinicians, in therapeutics, diagnostics, devices and digital health in 25 teams atUCSF, has just shown us the future of translational medicine. Its Lean, its fast, it works and its unlike anything else ever done.
Its going to get research from the lab to the bedside cheaper and faster.
Welcome to the Lean LaunchPad for Life Sciences and Healthcare (part of theNational Science Foundation I-Corps).
This post is part of our series on the Lean Startup in Life Science and Health Care.
Our class talked to 2,355 customers, tested 947 hypotheses and invalidated 423 of them. They had 1,145 engagements with instructors and mentors. (We kept track of all this data by instrumenting the teams withLaunchPad Central software.)
In a packed auditorium in Genentech Hall atUCSF,the teams summarized what they learned after 10 weeks of getting out of the building. This wasour version ofDemo Day we call it Lessons Learned Day. Each team make two presentations:
2 minutes YouTube Video: General story of what they learned from the class
In the next few posts Im going to share a few of the final Lessons Learned presentations and videos and then summarize lessons learned from the teaching team.
Their initial idea was that making ananastomosisthats better, faster and cheaper will have surgeons fighting to the death to get a hold of their device.They quickly found out that wasnt the case. Leak rates turned out to a bigger issue with surgeons and a much larger market.
To see their 2-minute video summary, clickhere.
Look at their Lesson Learned slides below and see how a team of doctors learned about product/market fit, channels and pricing. (Dont miss the evolution of their business model in the Appendix.)
To see the presentation , clickhere
The best summary of why Scientists, Engineers and Principal Investigators need to get out of the building was summarized by Dr. Harrison below.After working on his product for a decade listen to how 10 weeks of the Lean LaunchPad class radically changed his value proposition and business model.
For further reading:
Magnamosis IV: magnetic compression anastomosis for minimally invasive colorectal surgery
Magnamosis III: delivery of a magnetic compression anastomosis device using minimally invasive endoscopic techniques
Magnamosis II: Magnetic compression anastomosis for minimally invasive gastrojejunostomy and jejunojejunostomy
Magnamosis: magnetic compression anastomosis with comparison to suture and staple techniques
Gastro.org 2013 Education Meeting